233 related articles for article (PubMed ID: 13678639)
1. Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative.
Hotez PJ; Zhan B; Bethony JM; Loukas A; Williamson A; Goud GN; Hawdon JM; Dobardzic A; Dobardzic R; Ghosh K; Bottazzi ME; Mendez S; Zook B; Wang Y; Liu S; Essiet-Gibson I; Chung-Debose S; Xiao S; Knox D; Meagher M; Inan M; Correa-Oliveira R; Vilk P; Shepherd HR; Brandt W; Russell PK
Int J Parasitol; 2003 Sep; 33(11):1245-58. PubMed ID: 13678639
[TBL] [Abstract][Full Text] [Related]
2. Experimental approaches to the development of a recombinant hookworm vaccine.
Hotez PJ; Ghosh K; Hawdon JM; Narasimhan S; Jones B; Shuhua X; Sen L; Bin Z; Haechou X; Hainan R; Heng W; Koski RA
Immunol Rev; 1999 Oct; 171():163-71. PubMed ID: 10582170
[TBL] [Abstract][Full Text] [Related]
3. A history of hookworm vaccine development.
Schneider B; Jariwala AR; Periago MV; Gazzinelli MF; Bose SN; Hotez PJ; Diemert DJ; Bethony JM
Hum Vaccin; 2011 Nov; 7(11):1234-44. PubMed ID: 22064562
[TBL] [Abstract][Full Text] [Related]
4. Immunobiology of hookworm infection.
Loukas A; Constant SL; Bethony JM
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):115-24. PubMed ID: 15681140
[TBL] [Abstract][Full Text] [Related]
5. Molecular approaches to vaccinating against hookworm disease.
Hotez PJ; Hawdon JM; Cappello M; Jones BF; Ghosh K; Volvovitz F; Xiao SH
Pediatr Res; 1996 Oct; 40(4):515-21. PubMed ID: 8888276
[TBL] [Abstract][Full Text] [Related]
6. Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths.
Diemert DJ; Pinto AG; Freire J; Jariwala A; Santiago H; Hamilton RG; Periago MV; Loukas A; Tribolet L; Mulvenna J; Correa-Oliveira R; Hotez PJ; Bethony JM
J Allergy Clin Immunol; 2012 Jul; 130(1):169-76.e6. PubMed ID: 22633322
[TBL] [Abstract][Full Text] [Related]
7. Hookworm infections in human and laboratory animals--differences and similarities in immune responses.
Długosz E
Wiad Parazytol; 2005; 51(3):219-25. PubMed ID: 16913526
[TBL] [Abstract][Full Text] [Related]
8. Hookworm vaccines.
Diemert DJ; Bethony JM; Hotez PJ
Clin Infect Dis; 2008 Jan; 46(2):282-8. PubMed ID: 18171264
[TBL] [Abstract][Full Text] [Related]
9. Hookworm infection: new developments and prospects for control.
Bungiro R; Cappello M
Curr Opin Infect Dis; 2004 Oct; 17(5):421-6. PubMed ID: 15353961
[TBL] [Abstract][Full Text] [Related]
10. [Search for protective antigens of hookworms].
Wiśniewski M; Długosz E; Baska P; Wedrychowicz H
Wiad Parazytol; 2006; 52(4):271-6. PubMed ID: 17432617
[TBL] [Abstract][Full Text] [Related]
11. Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis.
Hotez PJ; Bethony JM; Oliveira SC; Brindley PJ; Loukas A
Expert Rev Vaccines; 2008 Aug; 7(6):745-52. PubMed ID: 18665774
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults.
Diemert DJ; Freire J; Valente V; Fraga CG; Talles F; Grahek S; Campbell D; Jariwala A; Periago MV; Enk M; Gazzinelli MF; Bottazzi ME; Hamilton R; Brelsford J; Yakovleva A; Li G; Peng J; Correa-Oliveira R; Hotez P; Bethony J
PLoS Negl Trop Dis; 2017 May; 11(5):e0005574. PubMed ID: 28464026
[TBL] [Abstract][Full Text] [Related]
13. Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum.
Mendez S; Zhan B; Goud G; Ghosh K; Dobardzic A; Wu W; Liu S; Deumic V; Dobardzic R; Liu Y; Bethony J; Hotez PJ
Vaccine; 2005 May; 23(24):3123-30. PubMed ID: 15837211
[TBL] [Abstract][Full Text] [Related]
14. Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate.
Curti E; Seid CA; Hudspeth E; Center L; Rezende W; Pollet J; Kwityn C; Hammond M; Matsunami RK; Engler DA; Hotez PJ; Elena Bottazzi M
Hum Vaccin Immunother; 2014; 10(7):1914-25. PubMed ID: 25424799
[TBL] [Abstract][Full Text] [Related]
15. Hookworm vaccines: past, present, and future.
Loukas A; Bethony J; Brooker S; Hotez P
Lancet Infect Dis; 2006 Nov; 6(11):733-41. PubMed ID: 17067922
[TBL] [Abstract][Full Text] [Related]
16. Hookworm infection: Toward development of safe and effective peptide vaccines.
Shalash AO; Hussein WM; Skwarczynski M; Toth I
J Allergy Clin Immunol; 2021 Dec; 148(6):1394-1419.e6. PubMed ID: 34872650
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals.
Bethony J; Loukas A; Smout M; Brooker S; Mendez S; Plieskatt J; Goud G; Bottazzi ME; Zhan B; Wang Y; Williamson A; Lustigman S; Correa-Oliveira R; Xiao S; Hotez PJ
FASEB J; 2005 Oct; 19(12):1743-5. PubMed ID: 16037096
[TBL] [Abstract][Full Text] [Related]
18. Hookworm and poverty.
Hotez P
Ann N Y Acad Sci; 2008; 1136():38-44. PubMed ID: 17954674
[TBL] [Abstract][Full Text] [Related]
19. The immunoepidemiology of human hookworm infection.
Quinnell RJ; Bethony J; Pritchard DI
Parasite Immunol; 2004; 26(11-12):443-54. PubMed ID: 15771680
[TBL] [Abstract][Full Text] [Related]
20. New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74.
Pearson MS; Jariwala AR; Abbenante G; Plieskatt J; Wilson D; Bottazzi ME; Hotez PJ; Keegan B; Bethony JM; Loukas A
Hum Vaccin Immunother; 2015; 11(5):1251-7. PubMed ID: 26018444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
